Henrik Johansson

Publications
CV
Public outreach and news

Articles

Article: MOLECULAR CELL. 2023;83(20):3720-3739.e8

FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.

Brunner A; Li Q; Fisicaro S; Kourtesakis A; Viiliäinen J; Johansson HJ; Pandey V; Mayank AK; Lehtiö J; Wohlschlegel JA; Spruck C; Rantala JK; Orre LM; Sangfelt O
Article: CANCER RESEARCH COMMUNICATIONS. 2022;2(6):434-446

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.

Silwal-Pandit L; Stålberg SM; Johansson HJ; Mermelekas G; Lothe IMB; Skrede ML; Dalsgaard AM; Nebdal DJH; Helland Å; Lingjærde OC; Labori KJ; Skålhegg BS; Lehtiö J; Kure EH
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(45):e2100050118

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.

Erdélyi K; Ditrói T; Johansson HJ; Czikora Á; Balog N; Silwal-Pandit L; Ida T; Olasz J; Hajdú D; Mátrai Z; Csuka O; Uchida K; Tóvári J; Engebraten O; Akaike T; Børresen Dale A-L; Kásler M; Lehtiö J; Nagy P
Article: NATURE CANCER. 2021;2(11):1224-1242

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.

Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer HM; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Foroughi Asl H; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Gram Hansen C; Drageset Haakensen V; Helland Å; Tamborero D; Johansson HJ; Branca RM; Planck M; Staaf J; Orre LM
Article: METABOLITES. 2021;11(5):310

Correcting for Naturally Occurring Mass Isotopologue Abundances in Stable-Isotope Tracing Experiments with PolyMID.

Jeong H; Yu Y; Johansson HJ; Schroeder FC; Lehtiö J; Vacanti NM
Article: FRONTIERS IN PHYSIOLOGY. 2021;12:689179

Fine Tuning of Phosphorothioate Inclusion in 2'-O-Methyl Oligonucleotides Contributes to Specific Cell Targeting for Splice-Switching Modulation.

Aoki Y; Rocha CSJ; Lehto T; Miyatake S; Johansson H; Hashimoto Y; Nordin JZ; Mager I; Aoki M; Graham M; Sathyaprakash C; Roberts TC; Wood MJA; Behlke MA; Andaloussi SE
Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(12):2047-2068

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

van Westering TLE; Johansson HJ; Hanson B; Coenen-Stass AML; Lomonosova Y; Tanihata J; Motohashi N; Yokota T; Takeda S; Lehtiö J; Wood MJA; El Andaloussi S; Aoki Y; Roberts TC
Article: BMC GENOMICS. 2020;21(1):590

Combined transcriptome and proteome profiling of the pancreatic β-cell response to palmitate unveils key pathways of β-cell lipotoxicity.

Lytrivi M; Ghaddar K; Lopes M; Rosengren V; Piron A; Yi X; Johansson H; Lehtiö J; Igoillo-Esteve M; Cunha DA; Marselli L; Marchetti P; Ortsäter H; Eizirik DL; Cnop M
Article: ELIFE. 2020;9:e57894

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

Brunner A; Suryo Rahmanto A; Johansson H; Franco M; Viiliäinen J; Gazi M; Frings O; Fredlund E; Spruck C; Lehtiö J; Rantala JK; Larsson L-G; Sangfelt O
Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(6):928-943

Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC.

Zhou Tran Y; Minozada R; Cao X; Johansson HJ; Branca RM; Seashore-Ludlow B; Orre LM
Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(6):1047-1057

DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis.

Zhu Y; Orre LM; Zhou Tran Y; Mermelekas G; Johansson HJ; Malyutina A; Anders S; Lehtiö J
Article: ISCIENCE. 2019;21:188-204

MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma.

Oliynyk G; Ruiz-Pérez MV; Sainero-Alcolado L; Dzieran J; Zirath H; Gallart-Ayala H; Wheelock CE; Johansson HJ; Nilsson R; Lehtiö J; Arsenian-Henriksson M
Journal article: PANCREATOLOGY. 2019;19:s155

The cellular proteome of pancreatic ductal adenocarcinoma

Silwal-Pandit L; Johansson H; Stålberg SM; Mermelekas G; Lothe I-MB; Skrede ML; Dalsgaard AM; Helland Å; Skålhegg BS; Labori KJ; Lingjærde OC; Lehtiö J; Kure E
Article: NATURE COMMUNICATIONS. 2019;10(1):1600

Breast cancer quantitative proteome and proteogenomic landscape.

Johansson HJ; Socciarelli F; Vacanti NM; Haugen MH; Zhu Y; Siavelis I; Fernandez-Woodbridge A; Aure MR; Sennblad B; Vesterlund M; Branca RM; Orre LM; Huss M; Fredlund E; Beraki E; Garred Ø; Boekel J; Sauer T; Zhao W; Nord S; Höglander EK; Jans DC; Brismar H; Haukaas TH; Bathen TF; Schlichting E; Naume B; Consortia Oslo Breast Cancer Research Consortium (; Luders T; Borgen E; Kristensen VN; Russnes HG; Lingjærde OC; Mills GB; Sahlberg KK; Børresen-Dale A-L; Lehtiö J
Article: FRONTIERS IN NEUROSCIENCE. 2019;13:1067

Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale.

Lee YXF; Johansson H; Wood MJA; El Andaloussi S
Article: SCIENTIFIC REPORTS. 2018;8(1):10813

Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome.

Sork H; Corso G; Krjutskov K; Johansson HJ; Nordin JZ; Wiklander OPB; Lee YXF; Westholm JO; Lehtiö J; Wood MJA; Mäger I; El Andaloussi S
Article: SCIENTIFIC REPORTS. 2018;8(1):9182

Extracellular nanovesicles released from the commensal yeast Malassezia sympodialis are enriched in allergens and interact with cells in human skin.

Johansson HJ; Vallhov H; Holm T; Gehrmann U; Andersson A; Johansson C; Blom H; Carroni M; Lehtiö J; Scheynius A
Article: BMC BIOLOGY. 2018;16(1):47

Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

Schmidt A; Marabita F; Kiani NA; Gross CC; Johansson HJ; Éliás S; Rautio S; Eriksson M; Fernandes SJ; Silberberg G; Ullah U; Bhatia U; Lähdesmäki H; Lehtiö J; Gomez-Cabrero D; Wiendl H; Lahesmaa R; Tegnér J
Article: NATURE COMMUNICATIONS. 2018;9(1):903

Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.

Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtiö J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(6):E1229-E1238

MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling.

Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
Article: SCIENTIFIC REPORTS. 2017;7(1):15453

Female mice lacking Pald1 exhibit endothelial cell apoptosis and emphysema.

Egaña I; Kaito H; Nitzsche A; Becker L; Ballester-Lopez C; Niaudet C; Petkova M; Liu W; Vanlandewijck M; Vernaleken A; Klopstock T; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Rask-Andersen H; Johansson HJ; Lehtiö J; He L; Yildirim AÖ; Hellström M; German Mouse Clinic Consortium
Article: ONCOTARGET. 2017;8(44):77061-77074

Identification of the PAK4 interactome reveals PAK4 phosphorylation of N-WASP and promotion of Arp2/3-dependent actin polymerization.

Zhao M; Spiess M; Johansson HJ; Olofsson H; Hu J; Lehtiö J; Strömblad S
Article: SCIENTIFIC REPORTS. 2016;6:22519

Cells release subpopulations of exosomes with distinct molecular and biological properties.

Willms E; Johansson HJ; Mäger I; Lee Y; Blomberg KEM; Sadik M; Alaarg A; Smith CIE; Lehtiö J; El Andaloussi S; Wood MJA; Vader P
Article: STEM CELLS. 2016;34(3):601-613

Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.

Anderson JD; Johansson HJ; Graham CS; Vesterlund M; Pham MT; Bramlett CS; Montgomery EN; Mellema MS; Bardini RL; Contreras Z; Hoon M; Bauer G; Fink KD; Fury B; Hendrix KJ; Chedin F; El-Andaloussi S; Hwang B; Mulligan MS; Lehtiö J; Nolta JA
Article: HUMAN MOLECULAR GENETICS. 2015;24(23):6756-6768

Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.

Roberts TC; Johansson HJ; McClorey G; Godfrey C; Blomberg KEM; Coursindel T; Gait MJ; Smith CIE; Lehtiö J; El Andaloussi S; Wood MJA
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2015;4(10):1199-1213

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalén M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Hägglund H; Mattsson M; Lehtiö J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
Article: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2015;11(4):879-883

Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties.

Nordin JZ; Lee Y; Vader P; Mäger I; Johansson HJ; Heusermann W; Wiklander OPB; Hällbrink M; Seow Y; Bultema JJ; Gilthorpe J; Davies T; Fairchild PJ; Gabrielsson S; Meisner-Kober NC; Lehtiö J; Smith CIE; Wood MJA; El Andaloussi S
Article: CLINICAL PROTEOMICS. 2015;12(1):8

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.

Johansson HJ; Sanchez BC; Forshed J; Stål O; Fohlin H; Lewensohn R; Hall P; Bergh J; Lehtiö J; Linderholm BK
Article: JOURNAL OF EXTRACELLULAR VESICLES. 2015;4:26883

Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles.

Li J; Lee Y; Johansson HJ; Mäger I; Vader P; Nordin JZ; Wiklander OPB; Lehtiö J; Wood MJA; Andaloussi SE
Article: JOURNAL OF PROTEOME RESEARCH. 2014;13(10):4424-4435

Investigating the applicability of antibodies generated within the human protein atlas as capture agents in immunoenrichment coupled to mass spectrometry.

Boström T; Johansson HJ; Lehtiö J; Uhlén M; Hober S
Article: MOLECULAR & CELLULAR PROTEOMICS. 2014;13(6):1611-1624

Immunoproteomics using polyclonal antibodies and stable isotope-labeled affinity-purified recombinant proteins.

Edfors F; Boström T; Forsström B; Zeiler M; Johansson H; Lundberg E; Hober S; Lehtiö J; Mann M; Uhlen M
Article: MOLECULAR & CELLULAR PROTEOMICS. 2014;13(3):701-715

Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.

Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
Article: PLOS ONE. 2014;9(2):e87951

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H; Johansson H; Höög A; Lehtiö J; Jakobsson P-J; Kjellman M
Article: NATURE METHODS. 2014;11(1):59-62

HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics.

Branca RMM; Orre LM; Johansson HJ; Granholm V; Huss M; Pérez-Bercoff Å; Forshed J; Käll L; Lehtiö J
Article: PROTEOMICS. 2013;13(23-24):3406-3410

Selectivity analysis of single binder assays used in plasma protein profiling.

Neiman M; Fredolini C; Johansson H; Lehtiö J; Nygren P-Å; Uhlén M; Nilsson P; Schwenk JM
Article: MOLECULAR & CELLULAR PROTEOMICS. 2013;12(7):2021-2031

Defining, comparing, and improving iTRAQ quantification in mass spectrometry proteomics data.

Hultin-Rosenberg L; Forshed J; Branca RMM; Lehtiö J; Johansson HJ
Article: MBIO. 2013;4(1):e00572-e00512

Genomic insights into the atopic eczema-associated skin commensal yeast Malassezia sympodialis.

Gioti A; Nystedt B; Li W; Xu J; Andersson A; Averette AF; Münch K; Wang X; Kappauf C; Kingsbury JM; Kraak B; Walker LA; Johansson HJ; Holm T; Lehtiö J; Stajich JE; Mieczkowski P; Kahmann R; Kennell JC; Cardenas ME; Lundeberg J; Saunders CW; Boekhout T; Dawson TL; Munro CA; de Groot PWJ; Butler G; Heitman J; Scheynius A
Article: NATURE COMMUNICATIONS. 2013;4:2175

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.

Johansson HJ; Sanchez BC; Mundt F; Forshed J; Kovacs A; Panizza E; Hultin-Rosenberg L; Lundgren B; Martens U; Máthé G; Yakhini Z; Helou K; Krawiec K; Kanter L; Hjerpe A; Stål O; Linderholm BK; Lehtiö J
Article: JOURNAL OF CELLULAR BIOCHEMISTRY. 2012;113(5):1635-1644

Thapsigargin down-regulates protein levels of GRP78/BiP in INS-1E cells.

Rosengren V; Johansson H; Lehtiö J; Fransson L; Sjöholm A; Ortsäter H
Article: MOLECULAR & CELLULAR PROTEOMICS. 2011;10(10):M111.010264

Enhanced information output from shotgun proteomics data by protein quantification and peptide quality control (PQPQ).

Forshed J; Johansson HJ; Pernemalm M; Branca RMM; Sandberg A; Lehtiö J
Article: PROTEIN SCIENCE. 2011;20(9):1520-1529

Penicillin-binding protein 5 can form a homo-oligomeric complex in the inner membrane of Escherichia coli.

Skoog K; Bruzell FS; Ducroux A; Hellberg M; Johansson H; Lehtiö J; Högbom M; Daley DO
Article: NUCLEIC ACIDS RESEARCH. 2011;39(9):3972-3987

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.

Andaloussi SEL; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PMD; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CIE; Langel U
Article: JOURNAL OF CONTROLLED RELEASE. 2009;134(3):221-227

A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.

Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
Article: BIOCONJUGATE CHEMISTRY. 2008;19(12):2535-2542

Distinct uptake routes of cell-penetrating peptide conjugates.

Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Article: JOURNAL OF PEPTIDE SCIENCE. 2008;14(12):1303-1308

Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes.

Arsov Z; Nemec M; Schara M; Johansson H; Langel U; Zorko M
Article: BIOCHEMICAL JOURNAL. 2008;412(2):307-313

Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.

Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2008;283(11):7046-7053

c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21.

Holmström TH; Mialon A; Kallio M; Nymalm Y; Mannermaa L; Holm T; Johansson H; Black E; Gillespie D; Salminen TA; Langel U; Valdez BC; Westermarck J
Article: MOLECULAR THERAPY. 2008;16(1):115-123

Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein.

Johansson HJ; El-Andaloussi S; Holm T; Mäe M; Jänes J; Maimets T; Langel Ü
Article: MOLECULAR THERAPY. 2008;16(1):115-123

Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.

Johansson HJ; El-Andaloussi S; Holm T; Mäe M; Jänes J; Maimets T; Langel U
Article: BIOCHEMICAL JOURNAL. 2007;407(2):285-292

Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.

El-Andaloussi S; Järver P; Johansson HJ; Langel U
Article: MOLECULAR THERAPY. 2007;15(10):1820-1826

A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.

El-Andaloussi S; Johansson HJ; Holm T; Langel U
Article: FASEB JOURNAL. 2007;21(11):2664-2671

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

Lundberg P; El-Andaloussi S; Sütlü T; Johansson H; Langel U
Article: JOURNAL OF GENE MEDICINE. 2006;8(10):1262-1273

Induction of splice correction by cell-penetrating peptide nucleic acids.

El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
Article: NATURE PROTOCOLS. 2006;1(2):1001-1005

Studying the uptake of cell-penetrating peptides.

Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
Article: JOURNAL OF CONTROLLED RELEASE. 2005;110(1):189-201

TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.

El-Andaloussi S; Johansson H; Magnusdottir A; Järver P; Lundberg P; Langel U
Show more

All other publications

Preprint: 2021;Research Square

Mass spectrometry-based proteomic analysis of NSCLC tumor and biopsy samples

Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
Preprint: 2021;Research Square

STK11 pathway in vitro validation

Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Staaf J; Orre L
Preprint: 2021;Research Square

Immune landscape evaluation of NSCLC clinical samples

Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
Preprint: 2021;Research Square

Bioinformatics analysis of NSCLC multi-omics data

Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer H; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Asl HF; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Hanson CG; Haakensen VD; Helland Å; Tamborero D; Johansson H; Branca R; Planck M; Staaf J; Orre L
Conference publication: CANCER RESEARCH. 2020;80(16):2371

FBXL12 modulates Fanconi anaemia-BRCA signaling under conditions of oncogene-induced replication stress

Brunner A; Johansson H; Kourtesakis A; Rantala J; Spruck C; Wohlschlegel J; Lehtio J; Sangfelt O
Corrigendum: SCIENTIFIC REPORTS. 2019;9(1):15014

Author Correction: Extracellular nanovesicles released from the commensal yeast Malassezia sympodialis are enriched in allergens and interact with cells in human skin.

Johansson HJ; Vallhov H; Holm T; Gehrmann U; Andersson A; Johansson C; Blom H; Carroni M; Lehtiö J; Scheynius A
Conference publication: MOLECULAR & CELLULAR PROTEOMICS. 2019;18(8):S40

Breast cancer quantitative proteome and proteogenomic landscape

Johansson HJ; Socciarelli F; Vacanti NM; Haugen MH; Zhu Y; Siavelis I; Fernandez-Woodbridge A; Aure MR; Sennblad B; Vesterlund M; Branca RM; Orre LM; Huss M; Fredlund E; Beraki E; Garred O; Boeke J; Sauer T; Zhao W; Nord S; Hoglander EK; Jans DC; Brismar H; Haukaas TH; Bathen TF; Schlichting E; Naume B; Luders T; Borgen E; Kristensen VN; Russnes HG; Lingjaerde OC; Mills GB; Sahlberg KK; Borresen-Dale A-L; Lehtio J
Corrigendum: NATURE COMMUNICATIONS. 2018;9(1):1852

Publisher Correction: Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.

Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtiö J
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):253

The role of extracellular vesicles (MalaEx) from the commensal yeast Malassezia sympodialis in atopic eczema

Vallhov H; Johansson H; Holm T; Gehrmann U; Johansson C; Andersson A; Lehtio J; Scheynius A
Conference publication: CANCER RESEARCH. 2016;76:3881

Breast cancer proteogenomics landscape defines subtype specific protein level regulations and reveals proteins coded by pseudogenic loci

Johansson H; Zhu Y; Haugland M; Sahlberg K; Fredlund E; Huss M; Vacanti N; Aure MR; Sennblad B; Kjellqvist S; Orre L; Lingjaerde OC; Borresen-Dale A-L; Lehtio J
Corrigendum: STEM CELLS TRANSLATIONAL MEDICINE. 2016;5(6):845

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalén M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Hägglund H; Mattsson M; Lehtiö J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;83(5):353

Integrative molecular profiling during human induced regulatory T cell (iTreg) generation reveals novel regulators of FOXP3

Schmidt A; Marabita F; Johansson H; Lehtio J; Eriksson M; Elias S; Gomez-Cabrero D; Rao A; Tegner J
Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S179-S180

MYC AND MITOCHONDRIAL METABOLISM IN CHILDHOOD NEUROBLASTOMA

Henriksson MA; Oliynyk G; Zirath H; Johansson H; Lehtio J
Conference publication: ANGIOGENESIS. 2013;16(1):271-272

Mechanistic studies on pericyte regulated functions at the neurovascular unit

Mae AM; Raschperger E; Keller A; Johansson H; Lavina-Siemsen B; Hofmann J; Olsson C; Lehtio J; Betsholtz C
Conference publication: ANGIOGENESIS. 2013;16(1):270-271

Mechanistic studies on pericyte regulated functions at the neurovascular unit

Mae AM; Keller A; Raschperger E; Johansson H; Lavina-Siemsen B; Hofmann J; Lehtio J; Betsholtz C
Conference publication: DIABETOLOGIA. 2012;55:S217

A proteomic investigation of the response induced by palmitate and thapsigargin in the insulin producing cell line INS-1E

Rosengren V; Johansson H; Lehtio J; Sjoholm A; Ortsater H
Conference publication: ANNALS OF ONCOLOGY. 2012;23:33-34

GENOME WIDE PROTEOMICS USING PEPTIDE HIGH RESOLUTION ISOELECTRIC FOCUSING HIRIEF-MS ALLOWS DETECTION NEW HUMAN GENE MODELS

Lehtio J; Branca M; Johansson H; Orre M; Granholm V; Forshed J; Perez-Bercoff M; Kall L
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):628

Proteomics-based characterization of potential biomarkers in tamoxifen resistance in breast cancer.

Sanchez BC; Johansson H; Forshed J; Stal O; Lehtio J; Linderholm BK
Meeting abstract: BREAST. 2011;20:S25

Identification and characterization of proteomic changes associated to tamoxifen-resistance in breast cancer cells

Sanchez BC; Johansson H; Lehtio J; Linderholm BK
Review: METHODS IN MOLECULAR BIOLOGY. 2011;683:233-247

Mimicry of protein function with cell-penetrating peptides.

Johansson HJ; Andaloussi SEL; Langel U
Conference publication: CANCER RESEARCH. 2010;70:4956

Proteomics-based characterization of pathways involved in tamoxifen resistance in breast cancer cells

Sanchez BC; Johansson H; Lehtio J; Stal O; Linderholm BK
Conference publication: ANNALS OF ONCOLOGY. 2010;21:41

PROTEOMICS PROFILING OF BREAST CANCER PATIENTS RECEIVING TAMOXIFEN

Johansson HJ; Sanchez BC; Bergh J; Linderholm B; Lehtio J
Conference publication: DIABETOLOGIA. 2009;52:S149

Protein levels of GRP78 and protein disulfide isomerases A3 and A6 are decreased during thapsigargin treatment of INS-1E cells

Rosengren V; Johansson H; Fransson L; Lehtio J; Sjoholm A; Ortsater H
Book chapter: 2006;p. 375-386

Cell-Penetrating Short Interfering RNAs and Decoy Oligonucleotides

El-Andaloussi S; Johansson H; Lundberg P; Langel U
Conference publication: JOURNAL OF PEPTIDE SCIENCE. 2004;10:190

INTERNALISATION OF SIRNA BY CELL PENETRATING PEPTIDES AND DOWN-REGULATION OF GALANIN RECEPTOR TYPE 1

Johansson HJ; Jarver P; Langel U
Show more

Employments

Senior Research Specialist, Department of Oncology-Pathology, Karolinska Institutet, 2022-

Degrees and Education

Docent, Karolinska Institutet, 2023

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI